SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFR14A - Revised definitive proxy soliciting materials:
SEC Accession No. 0001193125-06-113061
Filing Date
2006-05-16
Accepted
2006-05-15 18:38:20
Documents
5
Effectiveness Date
2006-05-16

Document Format Files

Seq Description Document Type Size
1 REVISED DEFINITIVE PROXY STATEMENT ddefr14a.htm DEFR14A 350276
2 GRAPHIC g83669image002rev.jpg GRAPHIC 29697
3 GRAPHIC g83669page_1.jpg GRAPHIC 134210
4 GRAPHIC g83669page_2.jpg GRAPHIC 154363
5 GRAPHIC g83669pdllogo2.jpg GRAPHIC 4057
  Complete submission text file 0001193125-06-113061.txt   796467
Mailing Address 34801 CAMPUS DR FREMONT CA 94555
Business Address 34801 CAMPUS DR FREMONT CA 94555 5105741400
PDL BIOPHARMA, INC. (Filer) CIK: 0000882104 (see all company filings)

IRS No.: 943023969 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFR14A | Act: 34 | File No.: 000-19756 | Film No.: 06843491
SIC: 2836 Biological Products, (No Diagnostic Substances)